Search results for "intermediate"

showing 10 items of 440 documents

The identification and localization of two intermediate filament proteins in the tunic of Styela plicata (Tunicata, Styelidae).

2009

The intermediate filament (IF) proteins Styela C and Styela D from the tunicate Styela (Urochordata) are co-expressed in all epidermal cells and they are thought to behave as type I and type II keratins. These two IF proteins, Styela C and Styela D, were identified in immunoblots of proteins isolated from the tunic of Styela plicata. The occurrence and distribution of these proteins within the tunic of this ascidian was examined by means of immunofluorescence and immunoperoxidase techniques, using anti-Styela C and anti-Styela D antibodies. In addition, immuno-electron microscopy of the tunic showed that the two proteins are located in the cuticle layer and in the tunic matrix. These result…

intermediate filamentchemistry.chemical_classificationbiologyIntermediate FilamentsTunicataCell BiologyGeneral MedicineAnatomyStyelabiology.organism_classificationStyelidaeCell biologyTunicateimmunolocalizationStyela plicatachemistryStyela plicataKeratinAnimalsKeratinsUrochordataUrochordataIntermediate filamentDevelopmental BiologyCuticle (hair)Tissuecell
researchProduct

History Matters: Colonial‑Based Connectivity and Foreign Headquarter Location Choice

2022

AbstractIn this study, we argue that European countries’ extensive relationships with former colonies represent a location factor that attracts foreign headquarter investments. The strategic role of foreign headquarters as coordinators, opportunity detectors, and global bridgeheads makes the location choice of headquarter activities sensitive to historical-based institutional connections. Drawing on a sample of 2230 foreign headquarter investments in Europe, we find that the stronger the combined effect of historical connections and current economic relationships with former colonies, the higher the probability of attracting headquarter investment projects. We refer to this combined charact…

intermediate headquarterscolonial linksStrategy and Managementforeign direct investmentinstitutionslocation choiceBusiness and International Managementforeign headquartersUNESCO::CIENCIAS ECONOMICAS
researchProduct

Experimental and computational studies of unconventional main group compounds : stable radicals and reactive intermediates

2017

Ever since their discovery, radicals have intrigued the minds of experimental and theoretical chemists alike. While the vast majority of radicals are transient species, a large number of stable and persistent radicals are also known. This has enabled the use of radicals in different applications. For example, radicals are highly useful in chemical synthesis due to their selectivity and functional group tolerance. Detailed knowledge of the electronic structure of synthetic intermediates, both radical and non-radical, enables chemists to improve existing synthesis routes and to design completely new ones. This thesis is divided into two parts. The first part begins with an introduction to the…

kemiallinen synteesisynthesiskemialliset yhdisteetkemialliset reaktiotspektroskopiastabilointi (kemia)reactive intermediatesmain group chemistryvapaat radikaalitreaktiivisuuslaskennallinen kemiacomputational chemistrystable radicalssivutuotteetröntgenkristallografiaEPR spectroscopyX-ray crystallography
researchProduct

Searches for lepton number violation and resonances in K± → πμμ decays

2017

The NA48/2 experiment at CERN collected a large sample of charged kaon decays to final states with multiple charged particles in 2003–2004. A new upper limit on the rate of the lepton number violating decay K±→π∓μ±μ± is reported: B(K±→π∓μ±μ±)<8.6×10−11 at 90% CL. Searches for two-body resonances X in K±→πμμ decays (such as heavy neutral leptons N4 and inflatons χ ) are also presented. In the absence of signals, upper limits are set on the products of branching fractions B(K±→μ±N4)B(N4→πμ) and B(K±→π±X)B(X→μ+μ−) for ranges of assumed resonance masses and lifetimes. The limits are in the (10−11,10−9) range for resonance lifetimes below 100 ps.

leptonBEAM01 natural sciences7. Clean energyPhysics Particles & FieldsHigh Energy Physics - ExperimentLIMITSkaon physicsCERNIntermediate statelepton number violation neutrinos dark matter kaon physicsPhysicsVMSMLarge Hadron ColliderPhysicsCharge KaonsneutrinosNuclear and High Energy Physics; CERN; leptonsHigh Energy Physics - Experiment; Charge Kaons; Lepton number violationNuclear & Particles PhysicsCharged particlelcsh:QC1-999NEUTRAL HEAVY-LEPTONSPhysics Nuclearlepton number violationPhysical SciencesParticle physicsNuclear and High Energy Physicsleptonskaon decays lepton number violationNuclear and High Energy Physics lepton kaon meson lepton number violation NA48Socio-culturaleAstronomy & AstrophysicsUPPER-BOUNDSdark matterNuclear physics0202 Atomic Molecular Nuclear Particle And Plasma Physics0103 physical sciencesDARK-MATTERPARTICLES010306 general physicsScience & Technologykaon decays010308 nuclear & particles physicsBranching fractionResonanceInflatonLepton numberkaon mesonNA48High Energy Physics::Experimentlcsh:PhysicsLepton
researchProduct

Determination of the Optimal Saddle Height for Leisure Cycling (P188)

2008

Several studies have been done on road racing cycling and triathlon to determine the optimal saddle height (LINF) in terms of efficiency. However, cycling is becoming nowadays not only a popular sport but also a mass mean of transport were comfort takes priority over efficiency. The aim of this study is to determine an optimal saddle height (LINF) to improve comfort in leisure cycling. Five male subjects (height mean=172.2 cm, std=1.34 cm; crotch height mean=81.25cm, std=0.88cm) tested 9 prototypes of the company ORBEA with 3 levels of LINF. The test consisted in one hour cycling in lab conditions and four different techniques were used to evaluate the LINF: 3-D movement analysis was used t…

medicine.anatomical_structurePeak pressureStatisticsCrotchmedicineBiomechanicsAnalysis of varianceKnee extensionCyclingIntermediate levelSaddleMathematics
researchProduct

Multidimensional Prognostic Index and Mortality in Intermediate Care Facilities: A Retrospective Study.

2021

Multidimensional prognostic index (MPI) is a frailty assessment tool used for stratifying prognosis in older hospitalized people, but data regarding older people admitted to intermediate care facilities (ICFs) are missing. The aim of this study is to evaluate whether MPI can predict mortality in older patients admitted to the ICFs. MPI was calculated using different domains explored by a standard comprehensive geriatric assessment and categorized into tertiles (MPI-1 ≤ 0.20, MPI-2 0.20–0.34, MPI-3 &gt

medicine.medical_specialtyIndex (economics)Intermediate Care FacilityArticle03 medical and health sciences0302 clinical medicineInternal medicineRisk of mortalityMedicine030212 general & internal medicinebusiness.industryHazard ratioRArea under the curveRegression analysisRetrospective cohort studyGeneral MedicinemortalityConfidence intervalmultidimensional prognostic indexintermediate careprognosis.Medicineprognosisbusiness030217 neurology & neurosurgeryJournal of clinical medicine
researchProduct

Expression of Cytokeratin 7 and 20 in Pathological Conditions of the Bile Tract

2003

Expression of cytokeratin 7 (CK7) and cytokeratin 20 (CK20) helps to establish the origin of biliary and metastatic carcinomas. We investigated the expression of CK7 and CK20 in inflammatory, metaplastic and neoplastic conditions of the bile ducts, and evaluated possible relationships between the CK expression pattern and extrahepatic bile duct/gallbladder carcinomas (EBDCs) or intrahepatic bile duct carcinomas (IBDCs). We used immunohistochemistry for the investigation of 48 formalin-fixed, paraffin-embedded specimens grouped as: A) lithiasic or inflamed surgically resected extrahepatic bile ducts/gallbladders: all were CK7+/CK20+; B) percutaneous liver biopsies from patients with chronic …

medicine.medical_specialtyPathologyIntestinal metaplasia2734Intrahepatic bile ductsBile duct tumors; Cytokeratin 20 (CK20); Cytokeratin 7 (CK7); Intestinal metaplasia; Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts Extrahepatic; Bile Ducts Intrahepatic; Carcinoma; Cell Transformation Neoplastic; Gallbladder Diseases; Gallbladder Neoplasms; Gene Expression Profiling; Humans; Immunohistochemistry; Intermediate Filament Proteins; Keratin-20; Keratin-7; Keratins; 2734Bile Duct DiseasesGallbladder DiseasesKeratin-20Settore MED/08 - Anatomia PatologicaGastroenterologyIntermediate Filament ProteinPathology and Forensic MedicinePrimary sclerosing cholangitisCytokeratinPrimary biliary cirrhosisIntermediate Filament ProteinsBile Ducts ExtrahepaticInternal medicineBile duct tumormedicineHumansCytokeratin 7 (CK7)Bile Duct NeoplasmGallbladder NeoplasmBile ductbusiness.industryGene Expression ProfilingGallbladderKeratin 20CarcinomaGallbladder DiseaseKeratin-7Bile Duct DiseaseCell Biologymedicine.diseaseImmunohistochemistryBile Ducts IntrahepaticCell Transformation Neoplasticmedicine.anatomical_structureBile Duct NeoplasmsKeratinKeratin 7KeratinsGallbladder NeoplasmsbusinessCytokeratin 20 (CK20)HumanPathology - Research and Practice
researchProduct

Luspatercept Response in ESA-NaïVe/RS+ Patients and RS- Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS)

2016

Abstract Background: Management of anemia is a common therapeutic challenge in patients with myelodysplastic syndromes (MDS). Luspatercept (ACE-536), a fusion protein containing modified activin receptor type IIB, is being developed for treatment of anemia in lower-risk MDS. Luspatercept binds GDF11 and other TGF-β superfamily ligands to promote late-stage erythroid differentiation and increase hemoglobin (Hgb) levels (Suragani R, Nat Med, 2014 and Attie K, Am J Hematol, 2014). Aims: This is an ongoing, phase 2, multicenter, open-label study to evaluate the effects of luspatercept in patient (pts) with low-intermediate risk MDS. Endpoints included erythroid response (IWG HI-E), RBC transfus…

medicine.medical_specialtyPediatricsbusiness.industryAnemiaMyelodysplastic syndromesImmunologyPhases of clinical researchCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyhemic and lymphatic diseasesPharmacodynamicsInternal medicineLuspaterceptCohortmedicineIntermediate riskbusinessLenalidomidemedicine.drugBlood
researchProduct

A first dedicated heart valve unit: safe and streamlined patient care for the rapidly growing field of transcatheter heart valve interventions

2021

Abstract Background A dedicated Heart Valve Unit was launched in 2018 to meet the demands of the growing transcatheter heart valve program by optimizing patient care in a single dedicated unit. Purpose To assess the performance of the heart valve unit (all steps of patient care in a single unit with intermediate care facilities) over a conventional approach (preparation on a normal ward, postprocedural intensive care unit (ICU) monitoring and transfer to an additional monitoring ward before discharge) in a high volume center. Methods Retrospective analysis including patients undergoing transcatheter mitral or tricuspid valve repair who were admitted to the Heart Valve Unit (02/2018–01/2020)…

medicine.medical_specialtyTricuspid valvebusiness.industryPsychological interventionHospital mortalityIntermediate Care FacilityIntensive care unitPatient carelaw.inventionmedicine.anatomical_structurelawmedicinePathologic fistulaHeart valveCardiology and Cardiovascular MedicineIntensive care medicinebusinessEuropean Heart Journal
researchProduct

Endovascular thrombectomy with the AngioJet System for the treatment of intermediate-risk acute pulmonary embolism: a case report of two patients

2016

Acute pulmonary embolism (PE) is one of the leading causes of death and ranks third, after myocardial infarction and cerebral stroke, among fatal hospital-related cardiovascular events [1–3]. Mortality associated with PE can be lowered by early treatments aimed at restoring patency of occluded pulmonary arteries (PAs). Although systemic thrombolysis remains the recommended management of PE [4], recent advances in endovascular techniques, especially of rheolytic thrombectomy, suggest that the endovascular approach can represent an alternative therapeutic strategy [5–9]. Here we describe endovascular treatment of two patients with acute PE. We used the AngioJet (Boston Scientific, Natick, MA,…

medicine.medical_specialtybusiness.industryShort Communicationmedicine.medical_treatmentMEDLINEThrombolysis030204 cardiovascular system & hematologyCerebral strokemedicine.diseaseSurgeryPulmonary embolism03 medical and health sciences0302 clinical medicineMedicine030212 general & internal medicineMyocardial infarctionEndovascular treatmentCardiology and Cardiovascular MedicinebusinessIntermediate riskTherapeutic strategyAdvances in Interventional Cardiology
researchProduct